Health care stocks were flat to higher premarket Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) recently inactive.
Iovance Biotherapeutics (IOVA) shares fell past 36% after the company lowered its 2025 product revenue guidance. The company also posted a wider-than-expected Q1 loss and revenue below expectations.
ANI Pharmaceuticals (ANIP) shares advanced by over 7% after the company reported higher Q1 adjusted earnings and revenue and raised its 2025 outlook.
Hims & Hers Health (HIMS) shares were down more than 4% after the company priced $870 million in 0% convertible senior notes due 2030 in a private offering to institutional investors, with closing expected on May 13.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。